This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Cataract Extraction
and you are
over 21
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

This study is being conducted to evaluate the intraocular penetration of Moxifloxacin 0.5% ophthalmic solution (Vigamox) and Besifloxacin 0.6% ophthalmic suspension (Besivance) after pre-operative topical administration in subjects undergoing cataract surgery.

Provided treatments

  • Drug: Moxifloxacin 0.5% ophthalmic solution
  • Drug: Besifloxacin 0.6% ophthalmic suspension
Tris trial is registered with FDA with number: NCT00924729. The sponsor of the trial is Johns Hopkins University and it is looking for 50 volunteers for the current phase.
Official trial title:
Parallel-group Study of Ocular Penetration of Peri-operative Topically Administered Fluoroquinolones With Cataract Surgery